Impact of enhanced bowel preparation on complications and prognosis following colonoscopic polypectomy

Table 1 Baseline characteristics of the study participants

Characteristic	Conventional bowel preparation group (n = 65)	Enhanced bowel preparation group (n = 65)	P value
Age (years)	55.2 ± 10.3	54.8 ± 10.5	0.82
Gender, n (%)
Male	38 (58.5)	37 (56.9)	0.85
Female	27 (41.5)	28 (43.1)
BMI (kg/m2)	24.1 ± 3.2	23.9 ± 3.1	0.78
Comorbidities, n (%)
Hypertension	15 (23.1)	14 (21.5)	0.89
Diabetes	8 (12.3)	7 (10.8)	0.81
Cardiovascular disease	5 (7.7)	4 (6.2)	0.76
Polyp characteristics
Number of polyps	1.3 ± 0.6	1.4 ± 0.5	0.42
Mean polyp size (mm)	8.2 ± 2.1	8.0 ± 2.0	0.68
Polyp type, n (%)
Adenomatous	40 (61.5)	42 (64.6)	0.72
Hyperplastic	20 (30.8)	19 (29.2)
Serrated	5 (7.7)	4 (6.2)
Previous colonoscopy, n (%)	10 (15.4)	11 (16.9)	0.85
Family history of colorectal cancer, n (%)	8 (12.3)	7 (10.8)	0.81
Current use of anticoagulants, n (%)	5 (7.7)	4 (6.2)	0.76
History of inflammatory bowel disease, n (%)	2 (3.1)	1 (1.5)	0.50

Values are presented as mean ± SD. BMI: Body mass index.